Apobetina

Apobetina is a medication containing Betahistine Dihydrochloride, used to improve blood flow in the inner ear. It is commonly prescribed for conditions related to vertigo and tinnitus. This oral medication is manufactured by Aurovitas Pharma Polska Sp. Z O.O.

Apobetina is primarily used to manage symptoms associated with vertigo and tinnitus. Betahistine Dihydrochloride works by improving blood circulation in the inner ear, which can help alleviate dizziness and ringing in the ears. This medication is often recommended for individuals experiencing these symptoms as part of their treatment plan.

Common effects of Apobetina may include mild gastrointestinal discomfort, such as nausea or stomach upset. Some users might also experience headaches or dizziness. These effects are generally temporary and should subside as the body adjusts to the medication. If any of these effects persist or worsen, it is advisable to consult a healthcare professional.

Apobetina should be used with caution in individuals with a history of peptic ulcers or asthma. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Pregnant or breastfeeding women should consult their doctor before using this medication. Always store Apobetina in a cool, dry place away from direct sunlight.

Apobetina may interact with certain medications, including those that affect blood pressure or other ear-related conditions. It is important to inform your healthcare provider about all the medications you are currently taking to avoid potential interactions. Additionally, consuming alcohol while taking Apobetina may increase the risk of side effects, so it is advisable to limit alcohol intake.